Deals channel feed – Endpoints News

Deals channel feed

Genmab enlists another antibody conjugate partner, teaming up with Bolt to develop up to 3 cancer programs

5 years ago

MorphoSys swoops in with a $1.7B deal to buy Constellation, adds $2B-plus in Royalty pact

5 years ago

Novartis plots 'next frontier' of MS treatment — and it could spell a buyout for a small Swiss player

5 years ago

Mirati wins over a Chinese partner for KRAS hopeful, looking to tail Amgen's breakthrough win

5 years ago

Amgen beefs up its late-stage pipeline with a $400M cash deal to go up against heavyweight rivals in a PhIII atopic dermatitis showdown

5 years ago

Looking to build new smart cells, BlueRock teams with Tim Lu's Senti Bio in 'second-order' engineering alliance

5 years ago

Three years after pivoting out of disaster, Vectura gets a $1.4B private equity buyout

5 years ago

UK begins inquiry into AstraZeneca's $39B buyout of Alexion

5 years ago

Alloy and Pyxis spin out new 'company' around high-risk I/O, immunology targets

5 years ago

Pieris inks respiratory partnership with Genentech, adding another to slate of milestone-heavy deals

5 years ago

The $70B question: What’s Pfizer going to do with all that Covid vaccine cash?

5 years ago

A CRO looking to build its manufacturing side business has a new parent after Keensight snaps up majority stake

5 years ago

Rare disease player that went public in biotech's go-go years merges with specialty pharma in all-stock deal — at a fraction of the debut price

5 years ago

A genetics testing outfit is bailing on its CRO services, choosing instead to refocus around precision drugs

5 years ago

Arie Belldegrun's vision for Ginkgo comes into view, as the now $15B company teams with Biogen on gene therapy

5 years ago

Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step

5 years ago

Bristol Myers bets big on anti-TIGIT bispecific from Agenus in a partnership worth $1.5B+

5 years ago

Charles River keeps adding on to its CDMO arm, snatching up a viral vector player for a tidy $350M

5 years ago

Perceptive's China upstart LianBio continues swinging deals, teaming up with lead Xontogeny biotech Landos in IBD

5 years ago

PerkinElmer hits the checkbook again, this time doling out $260M for next-gen therapy bioservices firm

5 years ago

Biogen pushes in a fresh stack of chips and starts prepping a global R&D game plan after watching the cards turn on early thrombolytic data

5 years ago

Biogen enlists under-the-radar AAV engineers as it pumps gene therapies into the pipeline

5 years ago

Lilly enlists a long-incubating RNA upstart in new $1.25B partnership

5 years ago

AbbVie makes a hefty play to boost aesthetics business, paying $550M for non-invasive body sculpting device

5 years ago

First page Previous page 76 77 787980 81 82 Next page Last page